From the Front Lines

My attention was drawn to this article at LEF News. I occasionally post items from the business world; meaningful anti-aging therapies will be delivered by corporate entities after they leave the labs. Here we see what looks like the powerhouses Geron and ACT validating the younger BioMarker Pharmaceuticals. This is a good sign! BioMarker is dedicated to developing therapies to retard aging. This article means that the big guys in the industry are taking this research very seriously.


Comment Submission

Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.